A recent debate on the results of the Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization trial or "EXCEL" that compares percutaneous coronary intervention (PCI) versus coronary artery bypass grafting surgery for the treatment of patients with left main stem coronary artery disease (LMCAD) has renewed discussions on "Conflict of Interest."
While this is not the platform for me to debate the rights, there is merit to explore the concept of "Conflict of Interest. " Why, well, because the EXCEL trial was industry-sponsored (Abbott Medical Devices) and the official title of the Randomized Interventional Clinical trial was "Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revasularisation. " Again, debating the righteousness of embarking on industry-sponsored trials as well as the merits and demerits of funding hurdles is beyond the scope of this editorial; however, it is important to elucidate "Conflict of Interest. "
The medical profession has always beyond doubt maintained high standards of self-regulation in ethics, governance, and transparency. Independent of the sponsor, the drive to maintain balance and/or be unbiased has always been beyond reprehension.
Any "Conflict of Interest" is declared in lectures and/ or publications; although one may question the validity of the nanosecond slide or the link of the presence of any conflict, this has not been a question because of the trust of self-regulation. We must strive not to lose this confidence, the voluntary self-certification, or face reprisals.
"Conflict of Interest" exists everywhere in normal dayto-day life, relatively minor and singular in consequence, for example, financial planning advisor recommending a product from which he expects to get a commission, that is, "nothing is free" mantra (free advice does not exist). Morally, the medical profession is also duty-bound by the "Hippocratic oath-First do no harm. " Dignifyingly, we are neither gullible nor blinded by any incentive to influence an outcome. The endeavor is, should be, and must be to preserve and protect the sanctity of trust. This will be more tested now, and in the future, for example, consider the "Apple Heart Study, " a wearable technology study to detect atrial fibrillation sponsored by private industry (Apple Inc., Cupertino, CA, USA), marketing directly to the general public (and patients) in direct contrast to the standard approach of scientific peer-reviewed conduct of a study and dissemination of results either at scientific presentations or peer-reviewed publications. This is an opportunity to buck the convention, collaborate, and engage to define the research path with ethics, governance, and transparency with the industry, patients, public, and the scientific community.
Every author publishing in this issue is unbiased, true in his or her evaluation and we as the Editorial Board do not hesitate to publish any negative or equivocal result rather than only the positive ones, as you the readers need to see every opinion in a fair, unbiased, and judicious way. As long as the science to do the study is ethical, balanced, fair, and transparent, the outcome is worth publishing. We do that in this journal, we promote that, and we strive to maintain that ethos.
The United Kingdom recently voted to leave the European Union (EU), and Brexit is almost guaranteed now as the recent election gave the Conservative Party a majority with Prime Minister Boris Johnson proposing a swift exit. It was the uncertainty that was unsettling and now the uncertainty has settled, we will be leaving the EU on 31 January 2020, and by the time this editorial is published, we will have left the EU (fingers crossed). We look forward to a new chapter-hopefully, a positive new chapter-and something that will renew and reinforce our values of no "Conflict of Interest. " I will end by quoting Friedrich Nietzsche's words, "whoever fights monsters should see to it that in the process he does not become a monster. And if you gaze long enough into an abyss, the abyss will gaze back into you. " Let us now be righteous about the conflict of interest-conflict of interest is everywhere, and we are all part of it in everyday lives, usually minor in consequence, however never without it. The best way to resolve conflict is without aggression, without retaliation, and with a meeting of terms across the table for the future of science.
